| Literature DB >> 35321326 |
Shuhao Fan1, Wensen Lin1, Yifan Huang1, Jiaojiao Xia1, Jun-Fa Xu1, Junai Zhang1, Jiang Pi1.
Abstract
Bacterial infection remains one of the most dangerous threats to human health due to the increasing cases of bacterial resistance, which is caused by the extensive use of current antibiotics. Photothermal therapy (PTT) is similar to photodynamic therapy (PDT), but PTT can generate heat energy under the excitation of light of specific wavelength, resulting in overheating and damage to target cells or sites. Polydopamine (PDA) has been proved to show plenty of advantages, such as simple preparation, good photothermal conversion effects, high biocompatibility, and easy functionalization and adhesion. Taking these advantages, dopamine is widely used to synthesize the PDA nanosystem with excellent photothermal effects, good biocompatibility, and high drug loading ability, which therefore play more and more important roles for anticancer and antibacterial treatment. PDA nanosystem-mediated PTT has been reported to induce significant tumor inhibition, as well as bacterial killings due to PTT-induced hyperthermia. Moreover, combined with other cancer or bacterial inhibition strategies, PDA nanosystem-mediated PTT can achieve more effective tumor and bacterial inhibitions. In this review, we summarized the progress of preparation methods for the PDA nanosystem, followed by advances of their biological functions and mechanisms for PTT uses, especially in the field of antibacterial treatments. We also provided advances on how to combine PDA nanosystem-mediated PTT with other antibacterial methods for synergistic bacterial killings. Moreover, we further provide some prospects of PDA nanosystem-mediated PTT against intracellular bacteria, which might be helpful to facilitate their future research progress for antibacterial therapy.Entities:
Keywords: anti-bacterial therapy; bacterial infections; biological functions and mechanisms; photothermal therapy; polydopamine nanosystem
Year: 2022 PMID: 35321326 PMCID: PMC8937035 DOI: 10.3389/fphar.2022.829712
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
FIGURE 1Schematic diagram of PDA nanomaterial synthesis, such as (A) PDA NPs (Liu et al., 2013), (B) Fe3O4@PDA/PEG/DOX NPs (Xue et al., 2017), (C) GNRs@PDA (Wang S. et al., 2016), and (D) PDA nanotubes (Xue et al., 2016).
FIGURE 2Different ways to enhance the antibacterial effect of the PDA nanosystem. (A) Specific antibody-enhanced targeting effects resulted in more effective bacterial killings in PDA nanosystem-mediated PTT. (B) Metal ions enhanced antibacterial effects in PDA nanosystem-mediated PTT; taking the PDA and glycol chitosan-coated gold nanorods (GCS-PDA@GNRs) as an example, the loading of silver ions into the nanosystem significantly enhanced the antibacterial efficiency (Liu et al., 2018). (C) ROS inductions to enhance the antibacterial effects of PDA nanosystem-mediated PTT, taking the phototherapeutic nanoplatform AI-MPDA composed of L-arginine (L-Arg), indocyanine green (ICG), and mesoporous PDA as an example (Yuan et al., 2020).
FIGURE 3Different ways to enhance the antibacterial effect of the PDA nanosystem. (A) DNAse I can be used to destroy cell membrane densification for enhanced antibacterial effects, taking the thermosensitive CO gas releasing donor (FeCO)-encapsulated MPDA NPs with covalently fixed deoxyribonuclease I (DNase-CO @MPDA NPs) as an example (Yuan et al., 2021). (B) Inhibition of heat shock protein accumulation to enhance antibacterial effects, taking the PDA-encapsulated Fe3O4 and 2-phenylethyl sulfonamide (PDA@Fe3O4+PES) as an example (Liu et al., 2016).
Typical study on antibacterial activity of the PDA nanosystem.
| Nanomaterial | Mechanism | Laser | Wavelength | Bacteria | References |
|---|---|---|---|---|---|
| Ag+-GCS-PDA@GNRs | Photothermal effect, metal ion release | NIR | 808 nm |
|
|
|
| |||||
| Cu-GA-CA-PDANRs | Drug delivery, photothermal effect | NIR | 808 nm |
|
|
|
| |||||
| CHX@CP3 | Drug delivery, photothermal effect | NIR | 808 nm |
|
|
| PPCP matrix | Drug delivery, photothermal effect | NIR | 808 nm |
|
|
| Van@ZIF-8@PDA | Drug delivery, photothermal effect | NIR | 808 nm |
|
|
|
| |||||
| PDA NP-Cip/GC hydrogel | Drug delivery, photothermal effect | NIR | 808 nm |
|
|
|
| |||||
|
| |||||
|
| |||||
| GT-DA/chitosan/CNT hydrogels | Drug delivery, photothermal effect | NIR | 808 nm |
|
|
|
| |||||
| SP@MX-TOB/GelMA | Drug delivery, photothermal effect | NIR | 808 nm |
|
|
|
| |||||
| DNAse-CO@MPDA | DNase active, photothermal effect, CO release | NIR | 808 nm | MRSA |
|
| AI-MPDA | ROS generation, NO release, photothermal effect | NIR | 808 nm |
|
|
| AuNC@PDA | Antigen antibody reaction to target cell membranes, photothermal effect, drug delivery | NIR | 808 nm |
|
|
|
| |||||
| Ab-Au@Ag-NRs | Antigen antibody reaction to target cell membranes, photothermal effect, metal ion release | NIR | 480–850 nm |
|
|
|
| |||||
| MoS2@PDA-PEG/IgG NSs | Antigen antibody reaction to target cell membranes, photothermal effect | NIR | 785 nm |
|
|
| MagI-PEG@PDA NP | Antibacterial peptide targeting bacterial effect, photothermal effect | NIR | 808 nm |
|
|
| PDA@Van-Ag | Photothermal effect, metal ion release, drug delivery | NIR | 808 nm |
|
|
|
| |||||
| PDA/Cu-CS hydrogel | Photothermal effect, metal ion release | NIR | 808 nm | MRSA |
|
|
| |||||
| GNR–PDA@Zn | Photothermal effect, metal ion release | NIR | 808 nm |
|
|
|
| |||||
| MoS2/PDA-RGD | Oxidative stress, photothermal effect | NIR | 808 nm |
|
|
|
| |||||
| PDA@Au-HAp | Oxidative stress, photothermal effect | NIR | 808 nm |
|
|
|
| |||||
| Ti-Nd-PDAFc | ROS generation, photothermal effect | NIR | 808 nm |
|
|
|
| |||||
| Ti-M/I/RGD | ROS generation, photothermal effect | NIR | 808 nm |
|
|
| PDA-Cur | ROS generation, photothermal effect | NIR | 808 nm |
|
|
|
| |||||
| PDA@Fe3O4+PES | photothermal effect, Inhibition of heat shock protein inhibitors | NIR | 785 nm |
|
|
|
|